[Skystar Bio-Pharmaceutical Reports 33% Growth in Revenue Fromntinuing Operations in Second Quarter Fiscal Year 2010 Gross Margin Remains of 53%; $0.33 Diluted Earnings Per Share;mpany reiterates fiscal 2010 guidance of $45.5 Million to $47.5 Million XIAN, CHINA August 17, 2010 -- -ystar Bio-Pharmaceuticalmpany (NASDAQ:SKBI) ("Skystar" or the "Company"),]
[Shanda Games Expresses Deep Condolences to Gansu Landslide Victims; Game Services Suspended for One Day SHANGHAI, China, Aug 16, 2010 (GlobeNewswire via COMTEX News Network) Shanda Games Limited (Shanda Games, or the Company) (Nasdaq:GAME), a leading online game developer, operator and publisher in China, today announced that in accordance with a public notice issued by the Chinese government on] [FORM 6-K Shanda Games Limited No. 1 Office Building Form 20-F Form 40-F. þ o Form 20-F Regulation S-T o Rule 101(b)(1): Regulation S-T o Rule 101(b)(7): Rule 12g3-2(b) o þ Yes Rule 12g3-2(b): 82- Shanda Games Limited Tan Qunzhao Chief executive officer Description Shanda Games Expresses Deep Condolences to Gansu Landslide Victims; Game Services Suspended for One Day 6-K]
[99.1 Press Release issued by thempany on August16, 2010: eLong Reports Second Quarter 2010 Unaudited Financial ResultsTED: August 17, 2010 ELONG, Mike Doyle Chief Financial Officer eLong Reports Second Quarter 2010 Unaudited Financial Results BEIJING, China August16, 2010 eLong, (Nasdaq: LONG), a leading online travel service provider in China, today reported unaudited financial results for]
[Shanda Games Expresses Deep Condolences to Gansu Landslide Victims; Game Services Suspended for One Day SHANGHAI, China, Aug 16, 2010 (GlobeNewswire via COMTEX News Network) Shanda Games Limited (Shanda Games, or the Company) (Nasdaq:GAME), a leading online game developer, operator and publisher in China, today announced that in accordance with a public notice issued by the Chinese government on] [FORM 6-K Shanda Games Limited No. 1 Office Building Form 20-F Form 40-F. þ o Form 20-F Regulation S-T o Rule 101(b)(1): Regulation S-T o Rule 101(b)(7): Rule 12g3-2(b) o þ Yes Rule 12g3-2(b): 82- Shanda Games Limited Tan Qunzhao Chief executive officer Description Shanda Games Expresses Deep Condolences to Gansu Landslide Victims; Game Services Suspended for One Day 6-K]
[99.1 Press Release issued by thempany on August16, 2010: eLong Reports Second Quarter 2010 Unaudited Financial ResultsTED: August 17, 2010 ELONG, Mike Doyle Chief Financial Officer eLong Reports Second Quarter 2010 Unaudited Financial Results BEIJING, China August16, 2010 eLong, (Nasdaq: LONG), a leading online travel service provider in China, today reported unaudited financial results for]
[Sinovac Reports Unaudited Second Quarter 2010 Financial Results - Conference call scheduled for Monday, August 16, 2010 at 8:00 AM EDT Beijing August 16, 2010 Sinovac Biotech Ltd. ( NASDAQ: SVA), a leading China-based vaccine manufacturer , announced today its un audited financial results for the three-month and six-month periods ended June 30, 2010. Financial Highlights ·] [1 -32371 SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, Peoples Republic of China Form 20-F x Form 40-F o o o SINOVAC BIOTECH LTD.]
[BIOSTAR PHARMACEUTICALS, SECOND QUARTER REVENUEREASED 46.4% TO $19.4 MILLION XIANYANG, China, August 17, 2010 - Q2 2010 revenuereased 46.4% to $19.4 million - Q2 2010 Non-GAAPjusted netomereased 50.9% to $5.8 million withjusted EPS of $0.21 - Biostar reiterates guidance for 2010: Revenue expected to be between $80.0 to $82.0 million and netome between $18.0 to]
[Sinovac Reports Unaudited Second Quarter 2010 Financial Results - Conference call scheduled for Monday, August 16, 2010 at 8:00 AM EDT Beijing August 16, 2010 Sinovac Biotech Ltd. ( NASDAQ: SVA), a leading China-based vaccine manufacturer , announced today its un audited financial results for the three-month and six-month periods ended June 30, 2010. Financial Highlights ·] [1 -32371 SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, Peoples Republic of China Form 20-F x Form 40-F o o o SINOVAC BIOTECH LTD.]
[BIOSTAR PHARMACEUTICALS, SECOND QUARTER REVENUEREASED 46.4% TO $19.4 MILLION XIANYANG, China, August 17, 2010 - Q2 2010 revenuereased 46.4% to $19.4 million - Q2 2010 Non-GAAPjusted netomereased 50.9% to $5.8 million withjusted EPS of $0.21 - Biostar reiterates guidance for 2010: Revenue expected to be between $80.0 to $82.0 million and netome between $18.0 to]
[FORM 10-Q/A x for the Quarterly Period Ended June 30, 2010 o for the Transition Period from _______ to _______ NF Energyvingrporation Delaware 02-0563302 (State or Other Jurisdiction oforporation or organization) (I.R.S. Employer Identification No.) 21-Jia Bei Si Dong Road, Tie Xi Qu Shenyang, P. R. China 110021] [Certifications I, Gang, Li, certify that: 1. I have reviewed this Amendment No. 1 to the quarterly report on Form 10-Q/A of NF Energyvingrporation. 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [Certifications I, Li Hua Wang, certify that: 1. I have reviewed this Amendment No. 1 to the Quarterly Report on Form 10-Q/A of NF Energyvingrporation. 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in] [SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (1) (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany for the six months ended June 30, 2010. NF Energyvingrporation Gang Li ( v194168_ex32-1.htm 4 EX-32.1] [SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (1) (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany for the six months ended June 30, 2010. NF Energyvingrporation Principal Financial and Accounting Officer) ( v194168_ex32-2.htm]
